查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
妊娠紋治療市場：按療法、最終用戶、地區規模、份額、展望、機會分析，2022-2028 年
市場調查報告書
商品編碼
1213837

妊娠紋治療市場：按療法、最終用戶、地區規模、份額、展望、機會分析，2022-2028 年

Stretch Marks Treatment Market, By Treatment, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

妊娠紋是皮膚快速拉伸或收縮時出現的一種痕跡。 妊娠紋可能出現在身體的不同部位，例如腹部、胸部、下背部和臀部。 這在懷孕期間、懷孕後和體重快速增加期間很常見。 妊娠紋無痛無害，但有些人擔心自己皮膚的外觀。 因此，全球對安全有效治療的需求不斷增長。

市場動態

全球肥胖負擔的增加、懷孕人數的增加、對安全有效治療的需求不斷增長、意識的提高以及對家庭局部治療的日益偏愛正在推動全球妊娠紋治療市場的增長。這是預期的主要因素來推動增長。

例如，2022 年 4 月，Skin Science Solutions 推出了新一代設備 icoone roboderm，它利用專有的細胞技術提供無痛、無創的面部和身體年輕化。。 icoone 技術為面部和身體提供廣泛的可定制和有效的治療，包括妊娠紋和減少皺紋。

2021 年 1 月，Dermaclara 推出了新的和改進的 Enhanced Silicone Fusion 妊娠紋貼片和套件。 由於尺寸、粘度、可重複使用性和透氣性方面的改進，新套件和貼片的整體效果比原始設計高 40%。

這項研究的主要特點

  • 本報告對全球妊娠紋治療市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR%) 增長情況。
  • 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 它根據以下參數介紹了全球妊娠紋治療市場的主要參與者，包括公司亮點、產品組合、主要亮點、績效和策略。
  • 本研究涵蓋的主要公司包括 Weleda、Union Swiss (Pty) Ltd.、Laboratoires Expanscience、HRA Pharma、Helix BioMedix Inc.、Dermaclara、Candela Corporation、Clarins Group、Basq Skin Care、Alliance Pharma PLC 和E.T. Browne Drug Co. Inc.（Palmers）等。
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 《全球妊娠紋治療市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球妊娠紋治療市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按療法分類
    • 市場概況：按最終用戶分類
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

  • 市場動態
    • 肥胖增加和懷孕增加
    • 激光和微晶換膚術的治療費用飆升
    • 對安全有效的妊娠紋治療的需求不斷增長
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/批准
  • 害蟲分析
  • 對 PORTER 的分析
  • 併購方案

第 4 章妊娠紋治療的全球市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學
  • 供應方和需求方分析
  • 經濟影響

第 5 章全球妊娠紋治療市場：按治療方式，2017-2028

  • 熱門產品
  • 激光
  • 其他治療

第 6 章全球妊娠紋治療市場：按最終用戶分類，2017-2028

  • 醫院和診所
  • 家用

第 7 章。全球妊娠紋治療市場：按地區劃分，2017-2028

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地方

第八章競爭格局

  • Weleda
  • Union Swiss（Pty）Ltd.
  • Laboratoires Expanscience
  • HRA Pharma
  • Helix BioMedix Inc.
  • Dermaclara
  • Candela Corporation
  • Clarins Group
  • Basq Skin Care
  • Alliance Pharma PLC
  • E. T. Browne Drug Co. Inc.（Palmers）

第 9 章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5466

Stretch mark is a kind of mark that occurs when the skin stretches or shrinks swiftly. Stretch marks commonly appear on the abdomen, breasts, hips, buttocks, or other parts of the body. Stretch marks often appear during or after pregnancy and after a sudden weight gain. Stretch marks aren't painful or harmful, but some people don't like the way they make their skin look. Thus, there is an increase in demand for safe and effective treatment worldwide.

Market Dynamics:

Growing burden of obesity across the world, increasing number of pregnancies, rise in demand for safe and effective treatment, rise in awareness, and rising preference for at-home topical treatments are major factors expected to drive growth of the global stretch marks treatment market.

For instance, in April 2022, Skin Science Solutions launched icoone roboderm, a new generation device that utilizes unique cellular technologies to offer painless and non-invasive facial and body rejuvenation. The icoone technology offers a wide range of customizable and effective treatments for both the face and body, including stretch marks and wrinkle reduction.

In January 2021, Dermaclara launched of newly improved Enhanced Silicone Fusion stretch mark patches and kit. With improvements to size, viscosity, reusability, and breathability, the new kit or patches have an overall increased effectiveness of 40% from its original design.

Key features of the study:

  • This report provides in-depth analysis of the global stretch marks treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stretch marks treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Weleda, Union Swiss (Pty) Ltd., Laboratoires Expanscience, HRA Pharma, Helix BioMedix Inc., Dermaclara, Candela Corporation, Clarins Group, Basq Skin Care, Alliance Pharma PLC, and E. T. Browne Drug Co. Inc. (Palmers), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global stretch marks treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stretch marks treatment market.

Detailed Segmentation:

  • Global Stretch Marks Treatment Market, By Treatment:
    • Topical Product
    • Laser
    • Other Treatments
  • Global Stretch Marks Treatment Market, By End User:
    • Hospitals and Clinics
    • Home Use
  • Global Stretch Marks Treatment Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Weleda
    • Union Swiss (Pty) Ltd.
    • Laboratoires Expanscience
    • HRA Pharma
    • Helix BioMedix Inc.
    • Dermaclara
    • Candela Corporation
    • Clarins Group
    • Basq Skin Care
    • Alliance Pharma PLC
    • E.T. Browne Drug Co. Inc. (Palmers)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Treatment
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing burden of obesity and increasing number of pregnancies
    • High cost of laser and microdermabrasion treatment
    • Increase in demand for safe and effective stretch marks treatment
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Stretch Marks Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Stretch Marks Treatment Market, By Treatment, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Topical Product
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Laser
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Treatments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Stretch Marks Treatment Market, By End User, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Home Use
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Stretch Marks Treatment Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Weleda
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Union Swiss (Pty) Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratoires Expanscience
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HRA Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Helix BioMedix Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dermaclara
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Candela Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clarins Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Basq Skin Care
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alliance Pharma PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • E. T. Browne Drug Co. Inc. (Palmers)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us